Skip to main content
UniHealth

Doctor search

Alison J Morris, NP

Nurse Practitioner · Stanford

NPI 1538539473

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
4
Since medical school
13 years
Graduated 2013

Offices

4 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Alison J Morris’s office to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$24,511

Medicare paid this office $24,511 for 142 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)96$16,698$108
Return visit (30+ min)50$4,281$70
Short return visit (20+ min)27$1,860$48
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's63$1,134$13

Who their Medicare patients are

142 Original Medicare patients in 2024. Average age 77 · Women 55% · Also on Medicaid 20% · Health risk score 2.89. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Cancer 49% · Chronic kidney disease 38% · Diabetes 35% · Coronary heart disease 30% · Atrial fibrillation 27% · Heart failure 21% · Depression 19% · COPD 16% · Dementia 9% · Stroke 8%.

The office billed $82,762, Medicare allowed $33,588 and paid $24,511; for 361 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024142361772.89$82,762$24,511
2023202407762.46$100,921$31,651
2022167325762.66$79,991$28,101
2021216402762.73$107,820$32,984
2020184275752.59$112,956$11,577
201990127742.16$91,673$4,503

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)102$15,068$103
Return visit (30+ min)114$12,445$71
Short return visit (20+ min)40$2,644$48

2022: 3 services

Original Medicare services billed in 2022
Long return visit (40+ min)107$17,242$113
Return visit (30+ min)84$8,824$71
Short return visit (20+ min)13$835$49

2021: 3 services

Original Medicare services billed in 2021
Return visit (30+ min)137$16,456$77
Long return visit (40+ min)75$12,087$116
Short return visit (20+ min)33$2,168$47

2020: 3 services

Original Medicare services billed in 2020
Short return visit (20+ min)124$6,628$38
Return visit (30+ min)62$4,329$60
Short return visit12$225$19

2019: 4 services

Original Medicare services billed in 2019
Short return visit (20+ min)50$2,763$39
Return visit (30+ min)14$1,037$61
Short return visit11$216$20
Office for the evaluation and management of established patient that may not require presence of healthcare professional24$172$7

Drugs they prescribed that Part D paid

$4,073,070

Pharmacies billed $4,073,070 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 2% of their Part D prescriptions (14 of 903) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

632 generic and fewer than 11 brand-name prescriptions · $4,073,070 in drug cost · 12 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tagrisso45$734,702$16,327
Ibrance30$457,868$15,262
Imbruvica25$409,607$16,384
Lenalidomide25$389,678$15,587
Pomalyst14$325,145$23,225
See all 25 drugs
Every Part D drug this clinician prescribed
Tagrisso45$734,702$16,327
Ibrance30$457,868$15,262
Imbruvica25$409,607$16,384
Lenalidomide25$389,678$15,587
Pomalyst14$325,145$23,225
Jakafi12$207,788$17,316
Erleada12$179,142$14,929
Brukinsa14$147,600$10,543
Eliquis31$27,199$877
Xarelto14$17,623$1,259
Abiraterone Acetate19$2,798$147
Letrozole72$1,730$24
Anastrozole90$1,589$18
Hydroxyurea51$1,487$29
Acyclovir47$840$18
Imatinib Mesylate12$784$65
Tamoxifen Citrate16$515$32
Gabapentin21$356$17
Dexamethasone18$250$14
Prednisone11$164$15
Potassium Chloride11$154$14
Omeprazole13$123$9
Allopurinol16$121$8
Ondansetron11$63$6
Alendronate24$48$2

Year by year

Part D prescribing by year
20249032792% (14)None$4,073,070
20231,0093224% (44)None$2,653,636
20221,0223317% (66)24%$2,418,234
20211,1233365% (61)20%$1,699,577
20203521547% (24)22%$439,241
20197537NoneNone$1,619
20181534011% (16)None$26,727
20175815NoneNone$1,934
20161002311% (11)None$9,817

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 25 drugs

Part D drugs prescribed in 2023
Revlimid32$595,704$18,616
Pomalyst15$339,628$22,642
Tagrisso17$286,886$16,876
Venclexta13$176,051$13,542
Lenalidomide12$175,212$14,601
Xarelto29$34,563$1,192
Imatinib Mesylate18$32,672$1,815
Eliquis29$28,891$996
Letrozole85$5,696$67
Exemestane11$3,680$335
Anastrozole70$2,598$37
Acyclovir59$2,207$37
Hydroxyurea55$1,889$34
Potassium Chloride11$1,718$156
Tamoxifen Citrate15$633$42
Diphenoxylate-Atropine12$482$40
Dexamethasone41$459$11
Gabapentin22$459$21
Hydrocodone-Acetaminophen22$368$17
Ondansetron20$316$16
Allopurinol24$281$12
Prednisone24$281$12
Prochlorperazine Maleate22$263$12
Pantoprazole16$80$5
Furosemide18$38$2

2022: 24 drugs

Part D drugs prescribed in 2022
Revlimid37$589,329$15,928
Tagrisso30$492,206$16,407
Jakafi19$283,837$14,939
Verzenio13$192,640$14,818
Eliquis40$26,740$669
Abiraterone Acetate15$17,927$1,195
Exemestane11$5,307$482
Letrozole90$2,641$29
Hydroxyurea49$2,536$52
Anastrozole73$2,322$32
Hydrocodone-Acetaminophen49$1,247$25
Acyclovir44$1,087$25
Gabapentin19$674$35
Potassium Chloride12$605$50
Tamoxifen Citrate17$514$30
Dexamethasone30$492$16
Ondansetron18$418$23
Allopurinol34$385$11
Prednisone20$325$16
Famotidine12$274$23
Pantoprazole17$270$16
Prochlorperazine Maleate18$225$13
Duloxetine16$200$12
Furosemide11$42$4

2021: 29 drugs

Part D drugs prescribed in 2021
Tagrisso45$743,663$16,526
Jakafi14$205,750$14,696
Eliquis46$27,897$606
Imatinib Mesylate29$27,074$934
Xarelto23$18,944$824
Anastrozole116$3,374$29
Letrozole63$2,640$42
Tamoxifen Citrate28$2,151$77
Hydroxyurea45$2,061$46
Ondansetron27$1,425$53
Acyclovir38$1,007$27
Duloxetine29$946$33
Mirtazapine13$926$71
Dexamethasone37$895$24
Valacyclovir15$806$54
Potassium Chloride11$598$54
Gabapentin24$568$24
Hydrocodone-Acetaminophen27$539$20
Pantoprazole30$397$13
Prednisone29$337$12
Hydrocortisone11$323$29
Oxycodone15$320$21
Prochlorperazine Maleate21$316$15
Venlafaxine Hcl Er15$280$19
Levothyroxine11$234$21
Diphenoxylate-Atropine11$217$20
Allopurinol18$206$11
Sulfamethoxazole-Trimethoprim13$179$14
Atorvastatin14$141$10

2020: 8 drugs

Part D drugs prescribed in 2020
Xarelto15$7,028$469
Hydroxyurea14$828$59
Letrozole11$702$64
Anastrozole19$573$30
Ondansetron15$316$21
Prochlorperazine Maleate12$181$15
Hydrocodone-Acetaminophen11$165$15
Acyclovir12$162$14

2018: 2 drugs

Part D drugs prescribed in 2018
Ondansetron17$114$7
Prochlorperazine Maleate12$55$5

Money from drug and device companies

$125 in 2025

Industry payments by year
202511None$125
202322None$45
202111None$25

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPLynparza$125
1 payment
  • Meals for Lynparza · 2025-07-17 · $125
See the published payment
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-07-17Lynparza$125
See earlier years (2023, 2021)

2023: $45

Payments by company in 2023
Novartis PharmaceuticalsKisqali$26
1 payment
  • Meals for Kisqali · 2023-11-10 · $26
GlaxoSmithKlineOjjaara$19
1 payment
  • Meals for Ojjaara · 2023-10-18 · $19

2021: $25

Payments by company in 2021
EisaiLenvima$25
1 payment
  • Meals for Lenvima · 2021-11-17 · $25

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1538539473
Licence
CA 95003816
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LF0000X (363LF0000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2015-10-05
NPI last updated
2025-12-24
NPI record certified
2025-12-24

This is when the NPI record was last certified, not a medical board exam.